RecruitingNCT05119387

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Genetisk Studie av Amyotrofisk Lateral Sklerose (ALS)

Sponsor

Sykehuset Telemark

Enrollment

1,200 participants

Start Date

Aug 1, 2019

Study Type

OBSERVATIONAL

Conditions

Amyotrophic Lateral Sclerosis

Summary

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Eligibility

Min Age: 16 YearsMax Age: 100 Years

Inclusion Criteria2

Probable or definite ALS
Eligible to consent

Exclusion Criteria1

\- not competent to give consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservation

Observation of genetic characteristics

Locations(17)

Haukeland University Hospital, Department of Neurology

Bergen, Norway

Nordland Hospital Trust, Department of Neurology

Bodø, Norway

Vestre Viken Hospital Trust, Department of Neurology

Drammen, Norway

Førde Hospital Trust, Department of Neurology

Førde, Norway

Østfold Hospital Trust, Department of Neurology

Grålum, Norway

Fonna Hospital Trust, Department of Neurology

Haugesund, Norway

Sørlandet Hospital Trust, Department of Neurology

Kristiansand, Norway

Innlandet Hospital Trust, Department of Neurology

Lillehammer, Norway

Akershus University Hospital, Department of Neurology

Lørenskog, Norway

Møre and Romsdal Hospital Trust, Department of Neurology

Molde, Norway

Nord-Trøndelag Hospital Trust, Department of Neurology

Namsos, Norway

Oslo University Hospital, Department of Neurology

Oslo, Norway

Telemark Hospital, Department of Neurology

Skien, Norway

Stavanger University Hospital, Department of Neurology

Stavanger, Norway

University hospital of North Norway, Department of Neurology

Tromsø, Norway

St. Olavs Hospital, Department of Neurology

Trondheim, Norway

Vestfold Hospital Trust, Department of Neurology

Tønsberg, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05119387

Related Trials

Ultra-high-caloric, Fatty Diet in ALS

NCT0628007923 locations

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT072900625 locations

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

NCT0728739711 locations

HEALEY ALS Platform Trial - Master Protocol

NCT0429768378 locations

The National Amyotrophic Lateral Sclerosis Registry

NCT017726021 location